Surgical approach for hepatitis C virus-related hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

http://www.wikidata.org/entity/Q26824046

about

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.

P2860

Q37338966-87A9E0CA-B8A3-47EF-AC71-B0B984DE97CB Q47547628-FD26DD8C-A7A4-412A-AD55-71EA3A03AA51

P2860

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

http://www.wikidata.org/entity/Q26824046

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

@ast

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

@en

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

@nl

type

label

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

@ast

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

@en

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

@nl

prefLabel

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

@ast

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

@en

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

@nl

P1433

Q26824046-0C23D966-7EF9-452D-98E9-9A3D2211193E

P1476

Q26824046-5FABBB51-905D-4FC9-AE0D-64477B3EE739

P2093

Q26824046-F84BF653-0378-41C1-8E65-0BE74E959CC6

P2860

Q26824046-03EF00BB-944F-4345-AB5D-DAB3EDBD05AF

Q26824046-0D306B88-BDE4-45EA-9A0A-2A8214ED8691

Q26824046-106B70C6-F0A2-4B00-9B9B-05F65B5458FC

Q26824046-1644776C-A286-4B1A-8E4A-9FBD7A54310E

Q26824046-1A07998E-2E49-425E-8273-AF5CEC6EDEAC

Q26824046-1CE8AB70-3B59-4E99-BAF2-2F243F7C95B5

Q26824046-255A0348-6A05-4CA9-A4F6-E45BBB14155E

Q26824046-2C617A59-40F0-4BCF-AD9A-B48814566290

Q26824046-2D4B4BCC-387F-4904-8A3E-65192A6A4FDD

Q26824046-3CEC6CF9-1094-4120-BE51-7338D8FC9E06

P304

Q26824046-64E81B88-C622-44CB-B2F6-9C656C0108EA

P31

Q26824046-F753866B-CC4E-4031-8B13-50F4899F66FC

P3181

Q26824046-AB62DE81-1A93-48E7-9A90-63C8629DD2CE

P356

Q26824046-B4C94964-32D7-4833-AE33-ECF9FE4D7DC8

P407

Q26824046-512A5194-FD7E-439A-8A60-18C479CB9542

P433

Q26824046-1F963C06-F96D-4472-8F1F-7D77C329FF0A

P478

Q26824046-48368954-C217-43C8-A66C-C63C537DBD1C

P577

Q26824046-A8E6D9F9-BA29-4CD5-80C4-682BE57CE99F

P5875

Q26824046-80DADD0F-000D-4DB2-8544-3D211865E6DD

P698

Q26824046-DFDE8991-AFD6-436A-83AD-749ACFC88030

P921

Q26824046-70C52BB0-7AB3-4693-9926-E851D8B2FD71

P932

Q26824046-C9D7CE85-3DCA-453E-AA58-266DA2D29D70

P3181

P356

P1433

World journal of hepatology

P1476

Surgical approach for hepatitis C virus-related hepatocellular carcinoma

@en

P2093

Junichi Shindoh

http://www.w3.org/2001/XMLSchema#string

P2860

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

Management of hepatocellular carcinoma: An update

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

Hepatocellular carcinoma

Epidemiology of viral hepatitis and hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.

Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

P304

70-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3203601

http://www.w3.org/2001/XMLSchema#string

P356

10.4254/WJH.V7.I1.70

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271593528

http://www.w3.org/2001/XMLSchema#string

P698

25624998

http://www.w3.org/2001/XMLSchema#string

P921

P932

4295196

http://www.w3.org/2001/XMLSchema#string